ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,521, issued on Dec. 2, was assigned to TOOLGEN Inc. (Seoul, South Korea).

"Platform for expressing protein of interest in liver" was invented by Seokjoong Kim (Seoul, South Korea), Dong Woo Song (Seoul, South Korea), Kyu Jun Lee (Seoul, South Korea), Jung-Min Lee (Gyeongsangbuk-do, South Korea) and Un-Gi Kim (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a platform for expressing a protein of interest by artificially manipulating the liver, and more particularly, to a platform for alleviating or treating a genetic disorder or improving a body function by inducing expression by inserting a transgene (e.g., a therapeutic...